是德科技 KEYS 深 沪
等待开盘 02-06 09:30:00 美东时间
221.52
-0.080
-0.04%
华盛通- 最 高223.2091
- 今 开218.94
- 成交量 78.45万股
- 最 低 214.49
- 昨 收 221.60
- 总市值 381.01亿
- 52周最高 232.92
- 市盈率 静 45.09
- 换手率 0.46%
- 52周最低 121.43
- 委 比 33.98%
- 总股本 1.72亿
- 历史最高 232.92
- 量 比 0.60
- 振 幅 3.93%
- 历史最低 21.071
- 每 手 1
- 风险率 21.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Keysight And Point2 Collaborate To Validate Ultra-Efficient e-Tube Multi-Terabit Interconnects For AI Data Centers
Collaboration validates Point2 Technology's innovative e-Tube™ multi-terabit interconnects using Keysight's high-speed digital test solutions, addressing critical power and bandwidth challenges in AI
01-30 00:03
同德同行，新启新程--东方中科连续十四年获得“是德科技租赁合作伙伴”授权
科学技术是第一生产力。科学技术不仅是生产力直接体现，更是社会进步和经济发展关键推动因素。科技兴则国运兴，科技强则国力强。 我国国民经济和社会发展第15个五年规划...
01-29 16:55
Keysight Technologies Inc. Announces Date for 2026 Annual Meeting of Stockholders
Keysight Technologies Inc. Announces Date for 2026 Annual Meeting of Stockholders Keysight Technologies Inc. will hold its 2026 Annual Meeting of Stockholders on March 19, 2026. During the meeting, shareholders will vote on the election of three directors to a three-year term, the ratification of th
01-27 07:47
$1000 Invested In Keysight Techs 10 Years Ago Would Be Worth This Much Today
Keysight Techs (NYSE:KEYS) has outperformed the market over the past 10 years b...
2025-12-30 05:30
Keysight Signs 5-Year Quantum Research Collaboration With Singapore's Top Institutions To Advance Quantum Computing
Keysight Technologies, Inc. (NYSE:KEYS) announced the signing of a five-year Master Research Collaboration Agreement (MRCA) with Singapore's leading quantum research institutions: Agency for Science, Technology and
2025-12-19 00:01
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
Jefferies Maintains Hold on Keysight Techs, Raises Price Target to $220
Jefferies analyst Saree Boroditsky maintains Keysight Techs (NYSE:KEYS) with a Hold and raises the price target from $195 to $220.
2025-12-11 02:45
高盛2026美股板块展望：工业科技股仍是“香饽饽” 汽车股需“精挑细选”
展望2026年，高盛预计，工业科技股将凭借周期复苏与长期增长机遇，继续跑赢市场;而对于汽车板块，鉴于行业销量已处于历史常态水平且未来增长乏力，投资者应采取精选策略。
2025-12-10 18:44
